in Duarte, California, has announced gifts totaling $50 million in support of an initiative at its to develop a cure for type 1 diabetes.
Led by a gift from Todd Wanek, CEO of , the world's largest home furniture manufacturer, and his family, the gifts will support the institute's , an effort to create highly focused programs aimed at attacking the problem of T1D in novel ways, with the ultimate goal of finding a cure within six years. To that end, the project will focus on three areas, each of which is crucial in treating both type 1 and type 2 diabetes: immune modulation, beta cell expansion and replacement, and preventing diabetes complications.
The $50 million total also includes gifts from an anonymous donor, individual supporters, and corporate and foundation partners.
Research conducted by City of Hope led to the development of synthetic human insulin, which is still used today by many of the estimated 1.5 million Americans with T1D and 27 million with type 2 diabetes. "City of Hope scientists' research has revolutionized the understanding and treatment of diabetes," said Wanek. "It continues today as physicians and scientists gain systemic understanding of diabetes as a complex, multifaceted disease."